A Phase 2 Double Blind, Randomized, Placebo Controlled Trial inVEstigating the Effect and Safety of Several Dosing Regimens of LY3056480 in Patients With STAble Sensorineural Hearing Loss
A phase 2 trial with LY3056480 in patients with stable SNHL
A phase I/II multiple ascending dose open-label safety and efficacy study of the Notch Inhibitor LY3056480 in patients with mild to moderate sensorineural hearing loss. - REGAIN
A phase I/II multiple ascending dose open-label safety and efficacy study of the Notch Inhibitor LY3056480 in patients with mild to moderate sensorineural hearing loss. - REGAIN
100 项与 LY-3056480 相关的临床结果
100 项与 LY-3056480 相关的转化医学
100 项与 LY-3056480 相关的专利(医药)
100 项与 LY-3056480 相关的药物交易